References
- Noronha V, Berliner N, Ballen KK, et al Treatment-related myelodysplasia/AML in a patient with a history of breast cancer and an oligodendroglioma treated with temozolomide: case study and review of the literature. Neuro Oncol 2006;8: 280–283.
- Tsangaris GT, Karamessinis P, Kolialexi A, et al Proteomic analysis of amniotic fluid in pregnancies with Down syndrome. Proteomics 2006;6:4410–4419.
- Ingraham BA, Bragdon B, Nohe A. Molecular basis of the potential of vitamin D to prevent cancer. Curr Med Res Opin 2008;24:139–149.
- Braoudaki M, Tzortzatou-Stathopoulou F, Anagnostopoulos AK, et al Proteomic analysis of childhood de novo acute myeloid leukemia and myelodysplastic syndrome/AML: correlation to molecular and cytogenetic analyses. Amino Acids 2010 Aug 14. [Epub ahead of print].
- Trump DL, Deeb KK, Johnson CS. Vitamin D: considerations in the continued development as an agent for cancer prevention and therapy. Cancer J 2010;16:1–9.
- Hassan MI, Waheed A, Yadav S, et al Zinc alpha 2-glycoprotein: a multidisciplinary protein. Mol Cancer Res 2008;6:892–906.
- Kim TE, Kim YW, Hwang SY, et al Candidate tumor suppressor, HCCS-1, is downregulated in human cancers and induces apoptosis in cervical cancer. Int J Cancer 2002;97: 780–786.
- López-Pedrera C, Villalba JM, Siendones E, et al Proteomic analysis of acute myeloid leukemia: identification of potential early biomarkers and therapeutic targets. Proteomics 2006; 6(Suppl. 1):S293–S299.
- Duval A, Olaru D, Campos L, et al Expression and prognostic significance of heat-shock proteins in myelodysplastic syndromes. Haematologica 2006;91:713–714.
- Verrills NM, Liem NL, Liaw TYE, et al Proteomic analysis reveals a novel role for the actin cytoskeleton in vincristine resistant childhood leukemia-an in vivo study. Proteomics 2006;6:1681–1694.